| Literature DB >> 27383910 |
Kelsey R Beavers1, Thomas A Werfel2, Tianwei Shen2, Taylor E Kavanaugh2, Kameron V Kilchrist2, Jeremy W Mares3, Joshua S Fain3, Carrie B Wiese4, Kasey C Vickers5, Sharon M Weiss3, Craig L Duvall6.
Abstract
Self-assembled polymer/porous silicon nanocomposites overcome intracellular and systemic barriers for in vivo application of peptide nucleic acid (PNA) anti-microRNA therapeutics. Porous silicon (PSi) is leveraged as a biodegradable scaffold with high drug-cargo-loading capacity. Functionalization with a diblock polymer improves PSi nanoparticle colloidal stability, in vivo pharmacokinetics, and intracellular bioavailability through endosomal escape, enabling PNA to inhibit miR-122 in vivo.Entities:
Keywords: PNA; anti-miRNA; nanocomposite; peptide nucleic acids; porous silicon
Mesh:
Substances:
Year: 2016 PMID: 27383910 PMCID: PMC5152671 DOI: 10.1002/adma.201601646
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849